MENU
+Compare
BEAM
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$29.02
Change
+$2.17 (+8.08%)
Capitalization
2.4B

BEAM Beam Therapeutics Forecast, Technical & Fundamental Analysis

a company, which develops and commercializes DNA base editing technologies for the treatment of human disease.

Industry Biotechnology
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for BEAM with price predictions
Dec 20, 2024

Momentum Indicator for BEAM turns positive, indicating new upward trend

BEAM saw its Momentum Indicator move above the 0 level on November 29, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned positive. In of the 94 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

BEAM moved above its 50-day moving average on November 22, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BEAM advanced for three days, in of 288 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 56 cases where BEAM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BEAM turned negative on December 18, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BEAM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BEAM broke above its upper Bollinger Band on December 10, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.036) is normal, around the industry mean (14.529). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). BEAM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (6.789) is also within normal values, averaging (255.281).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BEAM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BEAM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BEAM is expected to report earnings to rise 8.55% to -126 cents per share on March 04

Beam Therapeutics BEAM Stock Earnings Reports
Q4'24
Est.
$-1.27
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.20
Q4'23
Beat
by $2.42
The last earnings report on November 05 showed earnings per share of -116 cents, beating the estimate of -117 cents. With 2.74M shares outstanding, the current market capitalization sits at 2.40B.
A.I. Advisor
published General Information

General Information

a company, which develops and commercializes DNA base editing technologies for the treatment of human disease.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
238 Main Street
Phone
+1 857 327-8775
Employees
436
Web
https://www.beamtx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSESX16.610.18
+1.10%
Russell Inv US Strategic Equity S
HSLIX44.720.40
+0.90%
Hartford Small Cap Growth I
VBIAX50.330.38
+0.76%
Vanguard Balanced Index Adm
GFGEX12.76-0.90
-6.58%
Guardian Fundamental Glb Eq instl
JCAVX9.07-1.01
-10.01%
JHFunds2 Capital Appreciation Value NAV

BEAM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+8.04%
CRSP - BEAM
72%
Closely correlated
+0.83%
NTLA - BEAM
66%
Loosely correlated
+0.83%
DNLI - BEAM
64%
Loosely correlated
-0.19%
PRME - BEAM
62%
Loosely correlated
+3.94%
RXRX - BEAM
61%
Loosely correlated
-0.99%
More

Groups containing BEAM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+8.04%
BEAM
(3 stocks)
89%
Closely correlated
+3.23%